Education
About Us
Working with TipRanks
Follow Us
Envoy Medical, Inc. Class A (COCH)
:COCH
COCH Stock Chart & Stats
$0.72
-$0.05(-3.47%)
At close: 4:00 PM EST
$0.72
-$0.05(-3.47%)
Day’s Range― - ―
52-Week Range$0.64 - $2.32
Previous CloseN/A
Volume61.49K
Average Volume (3M)506.81K
Market Cap
$22.13M
Enterprise Value$14.34M
Total Cash (Recent Filing)$3.56M
Total Debt (Recent Filing)$946.00K
Price to Earnings (P/E)―
Beta0.37
Next Earnings
Apr 07, 2026EPS Estimate
-0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.35
Shares Outstanding28,786,510
10 Day Avg. Volume399,731
30 Day Avg. Volume506,813
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)-1.43
Price to Sales (P/S)119.42
P/FCF Ratio-1.42
Enterprise Value/Market Cap0.65
Enterprise Value/Revenue68.94
Enterprise Value/Gross Profit-23.43
Enterprise Value/Ebitda-0.73
Forecast
1Y Price Target
$5.50Price Target Upside663.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-1.13
Revenue Forecast (FY)$250.00K
Bulls Say, Bears Say
Bulls Say
Market OpportunityThe company believes there is a significant market opportunity, with an estimated 25,000 to 30,000 adults in the U.S. getting cochlear implants annually by 2026, representing a market opportunity exceeding $750 million.
Product InnovationEnvoy has developed the Acclaim CI, a fully implanted cochlear implant that does not require any external component to be worn on the ear.
Regulatory ApprovalThe Acclaim CI received approval for its IDE application with the FDA to begin clinical testing and has already started trials with participants.
Bears Say
Development RisksEnvoy Medical’s devices still have long development and/or commercialization roads ahead, with high risks of clinical trials or commercial failures.
Financial PerformanceRevenue was ~$0 million, compared to estimates of $0.1 million, leading to a net loss of $9.1 million or EPS of $(0.46).
Envoy Medical News
COCH FAQ
What was Envoy Medical, Inc. Class A’s price range in the past 12 months?
Envoy Medical, Inc. Class A lowest stock price was $0.64 and its highest was $2.32 in the past 12 months.
What is Envoy Medical, Inc. Class A’s market cap?
Envoy Medical, Inc. Class A’s market cap is $22.13M.
When is Envoy Medical, Inc. Class A’s upcoming earnings report date?
Envoy Medical, Inc. Class A’s upcoming earnings report date is Apr 07, 2026 which is in 132 days.
How were Envoy Medical, Inc. Class A’s earnings last quarter?
Envoy Medical, Inc. Class A released its earnings results on Nov 10, 2025. The company reported -$0.35 earnings per share for the quarter, missing the consensus estimate of -$0.24 by -$0.11.
Is Envoy Medical, Inc. Class A overvalued?
According to Wall Street analysts Envoy Medical, Inc. Class A’s price is currently Undervalued.
Does Envoy Medical, Inc. Class A pay dividends?
Envoy Medical, Inc. Class A does not currently pay dividends.
What is Envoy Medical, Inc. Class A’s EPS estimate?
Envoy Medical, Inc. Class A’s EPS estimate is -0.24.
How many shares outstanding does Envoy Medical, Inc. Class A have?
Envoy Medical, Inc. Class A has 28,786,510 shares outstanding.
What happened to Envoy Medical, Inc. Class A’s price movement after its last earnings report?
Envoy Medical, Inc. Class A reported an EPS of -$0.35 in its last earnings report, missing expectations of -$0.24. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Envoy Medical, Inc. Class A?
Currently, no hedge funds are holding shares in COCH
Company Description
Envoy Medical, Inc. Class A
Envoy Medical (COCH) is a pioneering company in the medical device sector, specializing in innovative solutions for hearing restoration. The company is best known for its flagship product, the Coclear Implant System, which provides a unique approach to treating severe to profound hearing loss. Envoy Medical operates within the healthcare industry, focusing on the development and commercialization of advanced implantable devices designed to improve the quality of life for individuals with hearing impairments.
COCH Stock 12 Month Forecast
Average Price Target
$5.50
▲(663.89% Upside)
Technical Analysis
EDAP TMS
―
Modular Medical
―
NeuroOne Medical Technologies
―
Vivos Therapeutics
―
Adagio Medical Holdings
―
Ownership Overview
37.01% Insiders
1.64% Mutual Funds
4.13% Other Institutional Investors
56.11% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---